Literature DB >> 21426233

18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis.

Leonardo Cavone1, Mirko Muzzi, Rita Mencucci, Bianca Sparatore, Marco Pedrazzi, Flavio Moroni, Alberto Chiarugi.   

Abstract

PURPOSE: High-mobility group proteins are chromatin-binding factors with key roles in nuclear homeostasis. Evidence indicates that extracellularly released high-mobility group box 1 protein (HMGB1) behaves as a cytokine, promoting inflammation and disease pathogenesis. HMGB1 release occurs during endophtalmitis or uveoretinitis.
METHODS: The authors investigated the presence of HMGB1 in tear fluid of patients with different inflammatory disorders of the external eye.
RESULTS: Data demonstrate that HMGB1 content is close to detection limit in tears of control subjects but highly increased (about 15-fold) in patients with conjunctivitis or blepharitis. The authors also report that 18β-glycyrrhetic acid impairs antibody recognition of HMGB1, suggesting direct binding to the protein. Accordingly, 18β-glycyrrhetic acid prevented HMGB1-dependent COX2 expression and cluster formation in primary cultures of human macrophages.
CONCLUSION: Together, these findings suggest that HMGB1 contributes to inflammatory disorders of the external eye, and 18β-glycyrrhetic acid may scavenge the protein and inhibit its detrimental effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426233     DOI: 10.3109/09273948.2010.538121

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  13 in total

1.  Allergic Rhinitis in Children: A Randomized Clinical Trial Targeted at Symptoms.

Authors:  Nicola Mansi; Gabriele D'Agostino; Antonella Silvia Scirè; Giada Morpurgo; Dario Gregori; Achal Gulati; Valerio Damiani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-02-11

2.  Impact of Low Humidity on Damage-associated Molecular Patterns at the Ocular Surface during Dry Eye Disease.

Authors:  Alyce Alven; Carolina Lema; Rachel L Redfern
Journal:  Optom Vis Sci       Date:  2021-11-01       Impact factor: 1.973

3.  Cytokine expression and barrier disruption in human corneal epithelial cells induced by alarmin released from necrotic cells.

Authors:  Ken Fukuda; Waka Ishida; Yusaku Miura; Tatsuma Kishimoto; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2017-07-19       Impact factor: 2.447

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  Increase in the Level of Proinflammatory Cytokine HMGB1 in Nasal Fluids of Patients With Rhinitis and its Sequestration by Glycyrrhizin Induces Eosinophil Cell Death.

Authors:  Leonardo Cavone; Caterina Cuppari; Sara Manti; Luisa Grasso; Teresa Arrigo; Luca Calamai; Carmelo Salpietro; Alberto Chiarugi
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

6.  Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.

Authors:  Sandamali A Ekanayaka; Sharon A McClellan; Ronald P Barrett; Shikhil Kharotia; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

7.  Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin.

Authors:  Xudong Peng; Sandamali A Ekanayaka; Sharon A McClellan; Ronald P Barrett; Kerry Vistisen; Linda D Hazlett
Journal:  Pathogens       Date:  2017-10-24

8.  HMGB1: A Promising Therapeutic Target for Prostate Cancer.

Authors:  Munirathinam Gnanasekar; Ramaswamy Kalyanasundaram; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla
Journal:  Prostate Cancer       Date:  2013-05-12

9.  Assessment of the tolerability profile of an ophthalmic solution of 5% glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy in the treatment of moderate to severe blepharitis.

Authors:  Rita Mencucci; Eleonora Favuzza; Ugo Menchini
Journal:  Clin Ophthalmol       Date:  2013-07-09

10.  Decreasing HMGB1 levels improves outcome of Pseudomonas aeruginosa keratitis in mice.

Authors:  Linda D Hazlett; Sharon A McClellan; Sandamali A Ekanayaka
Journal:  J Rare Dis Res Treat       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.